Royal Bank of Canada »

Ascendis Pharma AS shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.3M 27k 266.70

More positions owned by Royal Bank of Canada

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Rbc Cad (RY)
Alphabet Cap Stk Cl A (GOOGL)
Microsoft Corporation (MSFT)
Toronto Dominion Bk Ont Com New (TD)
Amazon (AMZN)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Bank Of Montreal Cadcom (BMO)
Alphabet Cap Stk Cl C (GOOG)
Cibc Cad (CM)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)

View all positions for Royal Bank of Canada

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS